Reflect Scientific, Inc. (RSCF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Reflect Scientific, Inc. (RSCF) trades at $0.04 with AI Score 39/100 (Grade D). Reflect Scientific, Inc. specializes in designing, developing, and selling scientific equipment for the life science and manufacturing industries. Market cap: $3.63M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for RSCF: RSCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RSCF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RSCF: 1/1 perspectives are bearish.
How is this calculated? →Reflect Scientific, Inc. (RSCF) Healthcare & Pipeline Overview
Reflect Scientific, Inc. provides specialized cooling and cryogenic solutions for the life science and manufacturing sectors, offering Cryometrix freezers and related consumables. The company serves a niche market requiring precise temperature control for storage and transportation, competing with larger players in the broader scientific equipment market.
What Is the Investment Thesis for RSCF?
Reflect Scientific, Inc. presents a focused investment opportunity within the specialized scientific equipment market. With a market capitalization of $3.63M and a P/E ratio of 57.29, the company's valuation reflects its growth potential and niche market position. A gross margin of 43.8% indicates efficient operations and pricing power. Key growth catalysts include expanding applications for Cryometrix freezers in vaccine storage and biopharmaceutical research. The company's ability to secure contracts with research institutions and pharmaceutical companies will drive revenue growth. However, the company's small size and OTC listing introduce liquidity and regulatory risks. Investors should monitor revenue growth, gross margin trends, and the company's ability to navigate the OTC market.
Based on FMP financials and quantitative analysis
RSCF Key Highlights
- Market capitalization of $3.63M reflects its small size and growth potential in the niche scientific equipment market.
- P/E ratio of 57.29 indicates investor expectations of future earnings growth.
- Gross margin of 43.8% demonstrates efficient operations and pricing power within its specialized product offerings.
- Profit margin of 5.3% shows profitability, but also highlights room for improvement in operational efficiency.
- Beta of 1.98 suggests higher volatility compared to the overall market, potentially due to its small market capitalization and OTC listing.
Who Are RSCF's Competitors?
RSCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ENZN Enzon Pharmaceuticals, Inc. | $4.35 | -8.42% | $28.76M | 42 |
| IDXG Interpace Biosciences, Inc. | $1.65 | +2.48% | $45.71M | 51 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| BLMHF Bloom Health Partners Inc. | $0.11 | +0.00% | $5.22M | 51 |
| FSPKF Fisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.23B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RSCF's Key Strengths?
- Specialized product line in ultra-low temperature solutions.
- Customizable product offerings.
- Established relationships with research institutions.
- Proprietary Cryometrix freezer technology.
What Are RSCF's Weaknesses?
- Small market capitalization and limited resources.
- Dependence on a niche market.
- OTC listing introduces liquidity risks.
- Limited brand recognition compared to larger competitors.
What Could Drive RSCF Stock Higher?
- Increasing demand for ultra-low temperature storage in vaccine development and biopharmaceutical research.
- Expansion of cold chain management solutions for pharmaceuticals and biological samples.
- Strategic partnerships with OEM manufacturers to integrate Reflect Scientific's products.
- Potential new contracts with research institutions and pharmaceutical companies.
- Development of advanced refrigerated transportation products.
What Are the Key Risks for RSCF?
- Financial-distress signal — its Altman Z-Score of -1.49 sits in the distress zone (elevated bankruptcy risk).
- Competition from larger, more established companies in the scientific equipment market.
- Regulatory changes affecting the medical device industry.
- Economic downturns impacting research funding and capital expenditures.
- OTC listing introduces liquidity and regulatory risks.
- Dependence on a niche market with limited growth potential.
What Are the Growth Opportunities for RSCF?
- Growth opportunity 1: Expansion of Cryometrix Freezer Applications: The increasing demand for ultra-low temperature storage in vaccine development and biopharmaceutical research presents a significant growth opportunity. The market for cryogenic storage solutions is projected to grow as personalized medicine and cell therapies gain traction. Reflect Scientific can capitalize on this trend by targeting research institutions and pharmaceutical companies with its Cryometrix freezers, offering specialized solutions for sensitive biological materials. Timeline: Ongoing.
- Growth opportunity 2: Development of Advanced Refrigerated Transportation Products: The cold chain management market is expanding due to the need for secure transportation of temperature-sensitive pharmaceuticals and biological samples. Reflect Scientific can develop advanced refrigerated transportation products that maintain ultra-low temperatures during transit. This includes partnerships with logistics companies and pharmaceutical manufacturers to provide end-to-end cold chain solutions. The market for refrigerated transportation is projected to grow, driven by the increasing globalization of pharmaceutical supply chains. Timeline: Ongoing.
- Growth opportunity 3: Strategic Partnerships with OEM Manufacturers: Collaborating with original equipment manufacturers (OEMs) in the chemical analysis industry can drive sales of Reflect Scientific's laboratory consumables and disposables. By integrating its products into OEM equipment, the company can secure recurring revenue streams and expand its market reach. The market for laboratory consumables is substantial, driven by the increasing volume of chemical analysis and research activities. Timeline: Ongoing.
- Growth opportunity 4: Penetration of International Markets: Expanding sales and distribution channels in international markets, particularly in Europe and Asia, can significantly boost revenue growth. This involves establishing partnerships with local distributors and tailoring products to meet the specific needs of international customers. The global market for scientific equipment is substantial, with significant growth potential in emerging economies. Timeline: Ongoing.
- Growth opportunity 5: Customization and Specialization of Product Offerings: Offering customized solutions and specialized product offerings tailored to specific customer needs can differentiate Reflect Scientific from competitors. This includes developing custom freezer configurations and specialized consumables for niche applications. By focusing on customization, the company can command premium pricing and build stronger customer relationships. The market for customized scientific equipment is growing, driven by the increasing complexity of research and development activities. Timeline: Ongoing.
What Opportunities Does RSCF Have?
- Expanding applications for ultra-low temperature storage in vaccine development.
- Growing demand for cold chain management solutions.
- Strategic partnerships with OEM manufacturers.
- Penetration of international markets.
What Threats Does RSCF Face?
- Competition from larger, more established companies.
- Regulatory changes affecting the medical device industry.
- Economic downturns impacting research funding.
- Technological advancements rendering existing products obsolete.
What Are RSCF's Competitive Advantages?
- Specialized expertise in ultra-low temperature technology.
- Customizable product offerings for niche applications.
- Established relationships with research institutions.
- Proprietary designs for Cryometrix freezers.
What Does RSCF Do?
Reflect Scientific, Inc., based in Orem, Utah, designs, develops, and sells scientific equipment tailored for the life science and manufacturing industries. The company's flagship product line, Cryometrix, features ultra-low temperature and blast freezers critical for storing sensitive materials like blood and cancer vaccines. Beyond freezers, Reflect Scientific provides a range of laboratory consumables and disposables, including filtration and purification products, customized sample handling vials, electronic wiring assemblies, and specialized sealing components. These components are essential for original equipment manufacturers (OEMs) in gas/liquid chromatography within the chemical analysis sector. Reflect Scientific's product portfolio also includes solvent chillers and refrigerated transportation solutions, catering to the cold chain management needs of various industries. The company serves a diverse clientele, including hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, government entities, and private sector research facilities. Reflect Scientific operates globally, providing solutions for cold chain management, chemical processing, and industrial applications. The company focuses on niche markets requiring precise temperature control and specialized equipment, differentiating itself through customized solutions and a focus on ultra-low temperature applications.
What Products and Services Does RSCF Offer?
- Designs and develops scientific equipment for life science and manufacturing.
- Offers Cryometrix ultra-low temperature and blast freezers.
- Provides laboratory consumables and disposables.
- Manufactures filtration and purification products.
- Creates customized sample handling vials.
- Offers solvent chillers and refrigerated transportation products.
- Serves hospitals, labs, pharmaceutical companies, and research facilities.
How Does RSCF Make Money?
- Direct sales of Cryometrix freezers and related equipment.
- Recurring revenue from consumables and disposables.
- Custom product development for specific client needs.
- Partnerships with OEMs for component integration.
What Industry Does RSCF Operate In?
Reflect Scientific, Inc. operates within the medical instruments and supplies industry, a segment driven by advancements in biotechnology, pharmaceutical research, and healthcare diagnostics. The global medical device market is projected to reach hundreds of billions of dollars by 2026, fueled by an aging population and increasing demand for advanced medical technologies. Reflect Scientific competes with companies like CBSC, CTABF, ENZN, FNAM, and IDXG, as well as larger players in the scientific equipment market. The company's focus on ultra-low temperature solutions and specialized consumables positions it within a niche segment of this broader market.
Who Are RSCF's Key Customers?
- Hospitals and diagnostic laboratories.
- Pharmaceutical and biotech companies.
- Universities and government research facilities.
- Cold chain management companies.
- Chemical and industrial companies.
Company Profile
Reflect Scientific, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Orem, US. The company is led by CEO Kim Boyce. RSCF has traded publicly since 2007.
F-Score 4/9Financial Health
Reflect Scientific, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.49 places it in the distress zone, a signal of elevated financial risk.
ROE 10%Key Financial Metrics
Return on equity for Reflect Scientific, Inc. stands at 10.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.4%, showing how much profit it generates from its asset base. RSCF trades at a trailing price-to-earnings ratio of 15.34, below the Healthcare sector average of ~23x. Its free cash flow yield is 19.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 8.14 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.5%, the inverse of the P/E and a quick read on earnings relative to price.
RSCF Valuation & Market Position
With a $3.63M market cap, Reflect Scientific, Inc. sits in the micro-cap segment of the market. Relative to its peer group, RSCF's quantitative score of 39/100 is below the peer average of 58/100.
Net buyingInsider Activity
The most recent 12 insider filings for Reflect Scientific, Inc. break down as 3 sales and 9 purchases. On net that is roughly 2.9M shares acquired (about $43K) — insiders putting money in tends to read as conviction.
RSCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that executives believe in the potential for growth.
- Community sentiment has shifted positively, with more discussions highlighting the innovative technologies Reflect Scientific is developing.
- The company's focus on expanding its product line in the cryogenic and refrigeration sectors has garnered attention from industry analysts.
- Recent partnerships and collaborations hint at potential market expansion, creating optimism among investors about future revenue streams.
Bear Case
- Concerns about the company's ability to scale production efficiently have been raised, leading to skepticism among some investors.
- Recent social media discussions show a faction of the community worried about the competitive landscape in the cryogenic market.
- Some analysts have pointed out that the company has faced delays in product launches, which could impact its market position.
- Overall market sentiment remains cautious, with broader economic factors potentially influencing investor confidence in smaller companies like Reflect Scientific.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RSCF Latest News
No recent news available for RSCF.
RSCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RSCF.
Price Targets
Wall Street price target analysis for RSCF.
RSCF MoonshotScore
What does this score mean?
The MoonshotScore rates RSCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kim Boyce
CEO
Kim Boyce serves as the CEO of Reflect Scientific, Inc. His leadership focuses on driving the company's growth through strategic partnerships and product innovation. His background includes experience in managing small teams and navigating the complexities of the scientific equipment market. He is responsible for overseeing the company's operations, sales, and marketing efforts.
Track Record: Under Kim Boyce's leadership, Reflect Scientific has focused on expanding its Cryometrix product line and securing contracts with research institutions. Key milestones include the development of customized freezer solutions and the establishment of partnerships with OEM manufacturers. His tenure has been marked by a focus on niche market opportunities and strategic growth initiatives.
RSCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Reflect Scientific, Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure, and investors should exercise caution due to the increased risk of fraud and manipulation compared to NYSE or NASDAQ-listed companies. OTC Other stocks often lack analyst coverage and institutional investment, contributing to lower liquidity and higher volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of information asymmetry.
- Lower trading volumes can lead to price volatility and illiquidity.
- OTC listing may attract speculative trading and potential market manipulation.
- Reduced regulatory oversight compared to major exchanges.
- Potential for delisting or trading suspension due to non-compliance.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Review the company's filings with the SEC or other regulatory agencies.
- Check for any legal or regulatory issues involving the company.
- Monitor trading activity and price movements for unusual patterns.
- Consult with a qualified financial advisor before investing.
- Established relationships with research institutions and pharmaceutical companies.
- Proprietary technology and specialized product offerings.
- Positive customer testimonials and case studies.
- Active participation in industry conferences and trade shows.
- Management team with relevant experience in the scientific equipment market.
RSCF Healthcare Stock FAQ
What does Reflect Scientific, Inc. do?
Reflect Scientific, Inc. specializes in designing, developing, and selling scientific equipment for the life science and manufacturing industries. The company's core offerings include Cryometrix ultra-low temperature freezers, essential for storing sensitive materials like blood and vaccines. Additionally, they provide laboratory consumables, disposables, solvent chillers, and refrigerated transportation products, catering to hospitals, research facilities, pharmaceutical companies, and industrial clients requiring precise temperature control and specialized equipment.
What do analysts say about RSCF stock?
As of 2026-03-17, there is no readily available analyst coverage for Reflect Scientific, Inc. (RSCF) due to its OTC listing and small market capitalization. Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. Key valuation metrics include the P/E ratio and gross margin, which provide insights into the company's profitability and efficiency.
What are the main risks for RSCF?
Reflect Scientific, Inc. faces several risks, including competition from larger companies, regulatory changes in the medical device industry, and economic downturns affecting research funding. The company's OTC listing introduces liquidity and regulatory risks, potentially leading to price volatility and limited access to capital. Additionally, its dependence on a niche market makes it vulnerable to shifts in demand and technological advancements that could render existing products obsolete.
What revenue streams does Reflect Scientific, Inc. have in healthcare?
Reflect Scientific, Inc.'s revenue streams in the healthcare sector primarily come from the sale of Cryometrix ultra-low temperature freezers to hospitals, diagnostic laboratories, and pharmaceutical companies. These freezers are used for storing blood, vaccines, and other temperature-sensitive biological materials. The company also generates revenue from the sale of laboratory consumables and disposables used in research and diagnostic procedures. The exact breakdown of revenue by product line and customer segment is Unknown.
How does Reflect Scientific, Inc. navigate regulatory approval processes?
As a manufacturer of scientific equipment and consumables, Reflect Scientific, Inc. must comply with relevant regulatory standards and approval processes in the countries where it operates. While specific details about the company's FDA/EMA regulatory track record are Unknown, it is likely that the company adheres to quality control standards and obtains necessary certifications for its products. Investors should monitor the company's compliance with regulatory requirements and any potential impact on its operations and financial performance.
What are the key factors to evaluate for RSCF?
Reflect Scientific, Inc. (RSCF) holds an AI score of 39/100 (low). Not financial advice.
How frequently does RSCF data refresh on this page?
RSCF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RSCF's recent stock price performance?
Reflect Scientific, Inc. (RSCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product line in ultra-low temperature solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Analyst coverage is non-existent.